Analysis Mycobacterium lepromatosis as the causative agent of diffuse lepromatous leprosy patient in Indonesia

##plugins.themes.bootstrap3.article.main##

MEDHI DENISA ALINDA
ABDUL KARIM
BAGUS H. KUSUMA PUTRA
ERY WIDAYATI
M. YULIANTO LISTIAWAN
DINAR ADRIATY
ISWAHYUDI
PUPUT ADE WAHYUNINGTYAS
CITA ROSITA PRAKOESWA

Abstract

Abstract. Adriaty D, Alinda MD, Karim A, Putra BHK, Agusni RI, Iswahyudi, Wahyuningtyas PA, Wahyuni R, Widayati E, Listiawan MY, Prakoeswa CR. 2023. Analysis Mycobacterium lepromatosis as the causative agent of diffuse lepromatous leprosy patient in Indonesia. Biodiversitas 24: 4521-4529. The present investigation deals with identifying, besides clinical signs, both microscopically and molecularly, to clearly differentiate the Mycobacterium lepromatosis genome against Mycobacterium leprae so that treatment can be carried out properly. To date, there has yet to be a report on this discovery in Indonesia. A 53-year-old Javanese man had ulceration on both legs that had been reoccurring in the past two years. Some of the ulcers were preceded by blisters that rapidly turned into a wound. The ulcers were described as wide and deep, covered with blackish crusts and some exudative areas with irregular edges. He had a history of recurrent epistaxis and had never been treated for leprosy. There was rapid progression and the development of new ulcers on his legs and hands for two weeks before hospitalization. There was body weakness, no fever, and the skin was shiny and ichthyosiform. On the face, diffuse infiltration will appear without nodules, and madarosis also occurs. Examination in this study used the BTA examination method, histopathological examination with HE and Wade-fite staining with biopsy material and the PCR method using skin slit smear material. The results of the BTA examination showed that BI was 3+, and MI showed 7%. Histopathology showed thinning of the epidermis with many foam cells containing BTA, including endnotes and perivascular tissues. Nested PCR examination with LERF2-MLER4 primers for detecting M. leprae showed a positive result with amplicon 135bp in size. Advanced PCR examination using LPMF2-MLER4 primers for detecting M. lepromatosis also showed a positive result with amplicons 142bp in size. The result of DNA sequencing was consistent with the order of nucleotides of M. lepromatosis. Based on the clinical and histopathological results, it was consistent with diffuse lepromatous leprosy and Lucio’s phenomenon. The DNA sequencing showed a suitable result with M. lepromatosis, which has been reported in Mexico. Thus, it can be concluded that in biomolecular strain, this bacterium is an M. lepromatosis that has never been reported in Indonesia.

##plugins.themes.bootstrap3.article.details##

References
Eichelmann K, Gonazales G, Alanis S, Candiani O. Leprosy. An update: Definition, pathogenesis, classification, diagnosis, and treatment. Actas dermesifiliogr. 2013; 104(7): 554-63
Thorat DM, Sharma P. Epidemiology. In: Kar HK, Kumar B, editors. Indian Association of Leprologist Textbook of Leprosy. New Delhi: Jaypee Brothers Medical Publishers Ltd; 2010. P. 24-31
Lee DJ, Rea TH, Modlin RL. Leprosy. In: Goldsmith LA, Katz SI, Gilchrest BA, Leffel DJ, Wolff K. Fitzpatrick’s Dermatology in General Medicine. 8th ed. New York: McGraw-Hill; 2012. P.2253-63
Smith WCS. Epidemiology of Leprosy. In: Makino M, Matsuoka M, Goto M, Hatano K, editors. Leprosy: Science working towards dignity. Hadano: Tokai University Press; 2011. P. 26-35
World Health Organization. Global leprosy: update on the 2012 situation. In: Weekly epidemiological record no.35; 2013,88:365-80
Kamath S, Vaccaro SA, Rea TH, Ochea MT. Recognizing and managing the immunologic reaction in leprosy. J am acad dermatol. 2014; 71: 795-803
Han XY, Sizer KC, Velarde-Felix JS, Frias-Castro LO, Vargas-Ocampo F. The leprosy agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico. Int J Dermatol 2012; 51: 952-9.
Jurado F, Rodriguez O, Novales J, Navarrete G, Rodriguez M. Lucio’s Leprosy: A clinical and treatment challenge. Clin. Dermatol. 2015; 33: 66-78
Kumari R, Thappa DM, Basu D. A fatal case of Lucio Phenomenon from India. Dermatol Online J 2008; 14 (2): 10
Ang P, Tay Y, Ng S, Seow C. Fatal Lucio’s phenomenon in 2 patients with previously undiagnosed leprosy. J Am Acad Dermatol 2003; 48: 958-61.
Monteiro R, Tiezzi MG, Olieveira CCM, Abreu MAMM, Roncada EVM, Ortigosa LCM. Lucio’s phenomenon: another case reported in Brazil. An bras dermatol. 2012; 87(2): 296-300
James WD, Berger TG, Elston MD. Andrews’ Diseases of The Skin Clinical Dermatology. 11thed. Philadelphia: Saunders Elsevier; 2011. p. 334-44.
Kavya M. Sacchidanand S. Lucio’s Phenomenon: A Rare Case Report. Int J Basic Appl Med Sci 2013; 3 (2): 325-30
Vargas-Ocampo F. Diffuse Leprosy of Lucio and Latapí: a Histologic Study. Lepr Rev 2007; 7: 248-60.
Massone C, Balachew WA, Schettini A. Histopathology of the lepromatous skin biopsy. Clin. Dermatol. 2015;33: 38-45
Peixoto AB, Leal FRPC, Rodrigues NCSR, Portela PS, Brotas AM. Lucio’s Phenomenon. Case study of an exceptional response to treatment exclusively with multibacillary multidrug therapy. An Bras Dermatol 2013; 88(6): S93-6
Ranugha PSS, Chandrashekar L, Kumari R, Thappa DM, Badhe B. Is it lucio phenomenon or necrotic erythema nodusum leprosum. Indian J dermatol. 2013; 58: 1-3
Curi PF, Villaroel JS, Migliore N, Albertengo A, Aquino ML, Ceccato F, et al. Lucio’s Phenomenon: report of five cases. Clin rheumatol. 2014:1-5
Sehgal VN. Lucio’s phenomenon/erythema necroticans. Int J dermatol. 2005; 44: 602-5
Han YX, Aung MF, Choon ES, Werner B. Analysis of the Leprosy Agents Mycobacterium leprae and Mycobacterium lepromatosis in Four Countries. Am J Clin Pathol 2014;142:524-532
Han XY, Seo S, Sizer KC, Schoberle T, May GS, Spencer JS, et al. A New Mycobacterium Species Causing Diffuse Lepromatous Leprosy. Am J Clin Pathol 2008;130: 856-64.
Gillis TP, Scollard DM, Lockwood DNJ. What is the evidence that the putative Mycobacterium lepromatosis species causes diffuse lepromatous leprosy?. Lepr Rev 2011; 82: 205-9.
Kowalska M, Kowalik A. Mycobacterium leprae: pathogenic agent in leprosy. Discovery of new species Mycobacterium lepromatosis. Perspectives in research and diagnosis of leprosy. Int Marit Health 2012;63(4):213-8.
Herath et al. Lucio’s phenomenon, an uncommon occurrence among leprosy patients in Sri Lanka. BMC Res Notes 2015;8:672
Kim J.Y, Chung K.Y, Kim J.W, Jung S.Y. Lucio phenomenon in nonendemic area of Northeast Asia. JEADV 2016;